Evaluating the efficacy of Antiseptic neem liquid & Antiseptic neem gel in subjects with various skin conditions.

A multicentric, double arm, open label prospective clinical study to evaluate the efficacy and safety of Investigational ayurvedic antiseptic products as Boroline’s Suthol Active Neem and Boroline’s Suthol Active Neem Gel in subjects having symptoms like prickly heat mosquito bite irritation due to summer or monsoon due to heat and sweat recent cut recent minor burn. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058801

Enrollment

100

Registered

2023-10-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Healthy males & female subjects in the age group of 13-45 years (both age inclusive). 2.Subject is having valid proof of identity and age. 3.Males & females having prickly heat/ mosquito bite/ irritation due to summer or monsoon due to heat and sweat/ recent cut/ recent minor burn. 4.Subjects representing normal, oily, dry and combination skin. 5.Subjects willing to give voluntary written informed consent. 6.Subjects willing to come for regular follow-up visits. 7.Subjects ready to follow instructions during the study period. 8.Subject willing to perform UPT (for females only).

Exclusion criteria

Exclusion criteria: 1.Subjects with Known hypersensitivity to any of the study products or constituents. 2.Subjects having topical or systemic treatment in the last month prior to participation in the study and during the study that could interfere with the study treatments/ assessments. 3.Subject is Pregnant or Lactating. 4.Subject with any significant medical condition that would interfere with the participation in the trial. 5.Subjects participated in any other cosmetic or therapeutic trial or in a similar investigation.

Design outcomes

Primary

Measure	Time frame
1 Reduction in Miliaria symptoms like reduction in eruption size number area covered pruritus erythema edema and excoriation 2 Reduction in discomfort like burning itching tingling and stingingTimepoint: Day 0 Screening and Baseline Day 3 Day 7 and Day 14.	—

Secondary

Measure	Time frame
Reduction in discomfort like burning itching tingling and stingingTimepoint: Day 0 Screening and Baseline Day 3 Day 7 and Day 14.	—

Countries

India

Contacts

Public ContactPurushotam Yadav

Auriga Research Private Limited

ct@aurigaresearch.com7889161551

Outcome results